Aibotics Inc. (AIBT)
OTCMKTS · Delayed Price · Currency is USD
0.0053
+0.0005 (10.42%)
Sep 24, 2025, 3:18 PM EDT
Aibotics Market Cap
Aibotics has a market cap or net worth of $1.25 million as of September 24, 2025. Its market cap has increased by 273.28% in one year.
Market Cap
1.25M
Enterprise Value
2.53M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 1.25M, a decrease of -97.01%. That is a compound annual growth rate of -52.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2025 | 1.14M | 1,016.45% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
| Jan 21, 2021 | 42.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 705.53M |
| Elite Pharmaceuticals | 686.78M |
| Glass House Brands | 538.12M |
| Northwest Biotherapeutics | 376.78M |
| CytoDyn | 351.92M |
| American Oncology Network | 341.95M |
| Nika Pharmaceuticals | 299.34M |